An evaluation of combined immunosuppression with MNA 715 and microemulsified cyclosporine on renal allograft rejection in mismatched mongrel dogs

Andrew E. Kyles, Clare R. Gregory, Stephen M. Griffey, Joshua Jackson, Lynda Bernsteen, Randall E. Morris

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objective - To evaluate a combination of MNA 715 and microemulsifed cyclosporine for the prevention of renal allograft rejection in mismatched mongrel dogs. Study Design - Randomized, experimental study. Animals - Fourteen female mismatched mongrel dogs. Methods - Heterotopic renal transplantation and bilateral nephrectomy were performed in each dog. Dogs were randomly assigned to receive either MNA 715 and cyclosporine (n = 8) or cyclosporine alone (n = 6). Dogs were killed at 100 days after transplantation or when plasma creatinine exceeded 7 mg/dL. Results - In the cyclosporine and MNA 715 group: 4 dogs survived to 100 days with normal plasma creatinine concentrations; 2 dogs with intestinal intussusceptions were killed at 5 and 8 days, 1 dog with a wound infection and sepsis was killed at 14 days, and 1 dog with a serum creatinine concentration >7 mg/dL was killed at 51 days postoperatively. In the cyclosporine-alone group: 3 dogs with acute rejection were killed at 6 to 9 days and 3 dogs survived to 100 days. In dogs treated with cyclosporine and MNA 715, survival to histologically confirmed acute rejection was significantly longer (P = .044) and the degree of mononuclear cell infiltration was significantly reduced (P = .040), compared with dogs treated with cyclosporine alone. Conclusions - MNA 715 combined with cyclosporine prolonged allograft survival and reduced the severity of histologic rejection in a clinically relevant renal transplant model. Clinical Relevance - An immunosuppressive regimen consisting of MNA715 and microemulsified cyclosporine may be effective in preventing allograft rejection in canine renal transplant patients.

Original languageEnglish (US)
Pages (from-to)358-366
Number of pages9
JournalVeterinary Surgery
Volume31
Issue number4
DOIs
StatePublished - Jul 2002

Fingerprint

graft rejection
cyclosporine
immunosuppression
Immunosuppression
Cyclosporine
Allografts
kidneys
Dogs
Kidney
dogs
kidney transplant
creatinine
Creatinine
2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-hepten-6-ynamide
Heterotopic Transplantation
Transplants
immunosuppressive agents
Intussusception
sepsis (infection)
allografting

ASJC Scopus subject areas

  • veterinary(all)

Cite this

An evaluation of combined immunosuppression with MNA 715 and microemulsified cyclosporine on renal allograft rejection in mismatched mongrel dogs. / Kyles, Andrew E.; Gregory, Clare R.; Griffey, Stephen M.; Jackson, Joshua; Bernsteen, Lynda; Morris, Randall E.

In: Veterinary Surgery, Vol. 31, No. 4, 07.2002, p. 358-366.

Research output: Contribution to journalArticle

Kyles, Andrew E. ; Gregory, Clare R. ; Griffey, Stephen M. ; Jackson, Joshua ; Bernsteen, Lynda ; Morris, Randall E. / An evaluation of combined immunosuppression with MNA 715 and microemulsified cyclosporine on renal allograft rejection in mismatched mongrel dogs. In: Veterinary Surgery. 2002 ; Vol. 31, No. 4. pp. 358-366.
@article{1b70df6353c4494a8ab9d8bd7534d759,
title = "An evaluation of combined immunosuppression with MNA 715 and microemulsified cyclosporine on renal allograft rejection in mismatched mongrel dogs",
abstract = "Objective - To evaluate a combination of MNA 715 and microemulsifed cyclosporine for the prevention of renal allograft rejection in mismatched mongrel dogs. Study Design - Randomized, experimental study. Animals - Fourteen female mismatched mongrel dogs. Methods - Heterotopic renal transplantation and bilateral nephrectomy were performed in each dog. Dogs were randomly assigned to receive either MNA 715 and cyclosporine (n = 8) or cyclosporine alone (n = 6). Dogs were killed at 100 days after transplantation or when plasma creatinine exceeded 7 mg/dL. Results - In the cyclosporine and MNA 715 group: 4 dogs survived to 100 days with normal plasma creatinine concentrations; 2 dogs with intestinal intussusceptions were killed at 5 and 8 days, 1 dog with a wound infection and sepsis was killed at 14 days, and 1 dog with a serum creatinine concentration >7 mg/dL was killed at 51 days postoperatively. In the cyclosporine-alone group: 3 dogs with acute rejection were killed at 6 to 9 days and 3 dogs survived to 100 days. In dogs treated with cyclosporine and MNA 715, survival to histologically confirmed acute rejection was significantly longer (P = .044) and the degree of mononuclear cell infiltration was significantly reduced (P = .040), compared with dogs treated with cyclosporine alone. Conclusions - MNA 715 combined with cyclosporine prolonged allograft survival and reduced the severity of histologic rejection in a clinically relevant renal transplant model. Clinical Relevance - An immunosuppressive regimen consisting of MNA715 and microemulsified cyclosporine may be effective in preventing allograft rejection in canine renal transplant patients.",
author = "Kyles, {Andrew E.} and Gregory, {Clare R.} and Griffey, {Stephen M.} and Joshua Jackson and Lynda Bernsteen and Morris, {Randall E.}",
year = "2002",
month = "7",
doi = "10.1053/jvet.2002.33615",
language = "English (US)",
volume = "31",
pages = "358--366",
journal = "Veterinary Surgery",
issn = "0161-3499",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - An evaluation of combined immunosuppression with MNA 715 and microemulsified cyclosporine on renal allograft rejection in mismatched mongrel dogs

AU - Kyles, Andrew E.

AU - Gregory, Clare R.

AU - Griffey, Stephen M.

AU - Jackson, Joshua

AU - Bernsteen, Lynda

AU - Morris, Randall E.

PY - 2002/7

Y1 - 2002/7

N2 - Objective - To evaluate a combination of MNA 715 and microemulsifed cyclosporine for the prevention of renal allograft rejection in mismatched mongrel dogs. Study Design - Randomized, experimental study. Animals - Fourteen female mismatched mongrel dogs. Methods - Heterotopic renal transplantation and bilateral nephrectomy were performed in each dog. Dogs were randomly assigned to receive either MNA 715 and cyclosporine (n = 8) or cyclosporine alone (n = 6). Dogs were killed at 100 days after transplantation or when plasma creatinine exceeded 7 mg/dL. Results - In the cyclosporine and MNA 715 group: 4 dogs survived to 100 days with normal plasma creatinine concentrations; 2 dogs with intestinal intussusceptions were killed at 5 and 8 days, 1 dog with a wound infection and sepsis was killed at 14 days, and 1 dog with a serum creatinine concentration >7 mg/dL was killed at 51 days postoperatively. In the cyclosporine-alone group: 3 dogs with acute rejection were killed at 6 to 9 days and 3 dogs survived to 100 days. In dogs treated with cyclosporine and MNA 715, survival to histologically confirmed acute rejection was significantly longer (P = .044) and the degree of mononuclear cell infiltration was significantly reduced (P = .040), compared with dogs treated with cyclosporine alone. Conclusions - MNA 715 combined with cyclosporine prolonged allograft survival and reduced the severity of histologic rejection in a clinically relevant renal transplant model. Clinical Relevance - An immunosuppressive regimen consisting of MNA715 and microemulsified cyclosporine may be effective in preventing allograft rejection in canine renal transplant patients.

AB - Objective - To evaluate a combination of MNA 715 and microemulsifed cyclosporine for the prevention of renal allograft rejection in mismatched mongrel dogs. Study Design - Randomized, experimental study. Animals - Fourteen female mismatched mongrel dogs. Methods - Heterotopic renal transplantation and bilateral nephrectomy were performed in each dog. Dogs were randomly assigned to receive either MNA 715 and cyclosporine (n = 8) or cyclosporine alone (n = 6). Dogs were killed at 100 days after transplantation or when plasma creatinine exceeded 7 mg/dL. Results - In the cyclosporine and MNA 715 group: 4 dogs survived to 100 days with normal plasma creatinine concentrations; 2 dogs with intestinal intussusceptions were killed at 5 and 8 days, 1 dog with a wound infection and sepsis was killed at 14 days, and 1 dog with a serum creatinine concentration >7 mg/dL was killed at 51 days postoperatively. In the cyclosporine-alone group: 3 dogs with acute rejection were killed at 6 to 9 days and 3 dogs survived to 100 days. In dogs treated with cyclosporine and MNA 715, survival to histologically confirmed acute rejection was significantly longer (P = .044) and the degree of mononuclear cell infiltration was significantly reduced (P = .040), compared with dogs treated with cyclosporine alone. Conclusions - MNA 715 combined with cyclosporine prolonged allograft survival and reduced the severity of histologic rejection in a clinically relevant renal transplant model. Clinical Relevance - An immunosuppressive regimen consisting of MNA715 and microemulsified cyclosporine may be effective in preventing allograft rejection in canine renal transplant patients.

UR - http://www.scopus.com/inward/record.url?scp=0036651222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036651222&partnerID=8YFLogxK

U2 - 10.1053/jvet.2002.33615

DO - 10.1053/jvet.2002.33615

M3 - Article

C2 - 12094350

AN - SCOPUS:0036651222

VL - 31

SP - 358

EP - 366

JO - Veterinary Surgery

JF - Veterinary Surgery

SN - 0161-3499

IS - 4

ER -